Detalhe da pesquisa
1.
Calcification of surgical aortic bioprostheses and its impact on clinical outcome.
Eur Heart J Cardiovasc Imaging
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606926
2.
Comorbidities may offset expected improved survival after transcatheter aortic valve replacement.
Eur Heart J Open
; 2(3): oeac029, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35919341
3.
Carotid versus femoral access for transcatheter aortic valve replacement: comparable results in the current era.
Eur J Cardiothorac Surg
; 60(4): 874-879, 2021 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724380
4.
Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy.
Circulation
; 115(1): 40-9, 2007 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-17190868
5.
Could anticoagulation avoid bioprosthesis subclinical thrombosis in patients undergoing transcatheter aortic valve replacement?
Arch Cardiovasc Dis
; 111(1): 25-32, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28943264
6.
Familial aggregation of calcific aortic valve stenosis in the western part of France.
Circulation
; 113(6): 856-60, 2006 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-16461814
7.
Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.
Am J Cardiol
; 95(5): 700-2, 2005 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15721128
8.
Identification of a strong genetic background for progressive cardiac conduction defect by epidemiological approach.
Heart
; 98(17): 1305-10, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22717692